What are the treatment options for eczema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Eczema

The management of eczema follows a stepwise approach, with topical corticosteroids being the first-line treatment for flare-ups, followed by topical calcineurin inhibitors, phototherapy, and systemic therapies for more severe cases that don't respond to initial treatments. 1

First-Line Treatment

Moisturizers and Skin Care

  • Apply emollients liberally and frequently, especially after bathing
  • Use soap-free cleansers for bathing
  • Continue moisturizer use even when skin appears clear

Topical Corticosteroids

  • Potency selection:

    • Mild eczema: Mild-potency corticosteroids
    • Moderate eczema: Moderate-potency corticosteroids
    • Severe eczema: Potent corticosteroids for short periods 1, 2
  • Application frequency:

    • Once-daily application of potent corticosteroids is as effective as twice-daily application 2
    • Apply to affected areas only
  • Duration:

    • Use for short periods during flares
    • Stop when signs and symptoms (itching, rash, redness) resolve 3

Topical Calcineurin Inhibitors (TCIs)

  • Options include pimecrolimus (Elidel) and tacrolimus
  • Particularly useful for:
    • Sensitive areas (face, neck, skin folds)
    • When concerned about steroid side effects
    • Maintenance therapy 1, 3
  • Pimecrolimus is indicated for patients 2 years and older 3
  • Do not use continuously for long periods 3

Second-Line Treatment

Proactive Maintenance Therapy

  • Weekend (twice weekly) application of topical corticosteroids or TCIs to previously affected areas reduces relapse risk by more than 50% 2
  • Helps prevent recurrent flares

Phototherapy

  • Consider when topical therapies fail to control symptoms
  • Narrow-band UVB is most commonly recommended 1
  • May cause long-term adverse effects such as premature skin aging and cutaneous malignancies 4

Third-Line Treatment

Systemic Therapies

  • Reserved for severe, recalcitrant cases that don't respond to topical treatments

  • Options include:

    • Dupilumab (first FDA-approved biologic for atopic dermatitis)
    • Tralokinumab
    • JAK inhibitors
    • Immunomodulators (cyclosporine, methotrexate, azathioprine, mycophenolate mofetil) 1, 5
  • Systemic corticosteroids:

    • Have limited role in severe atopic eczema
    • Should not be used for maintenance treatment
    • Can lead to rebound flares when discontinued 4, 1

Adjunctive Treatments

Infection Prevention and Management

  • Bleach baths (0.005% sodium hypochlorite twice weekly) help prevent infections
  • Systemic antibiotics only when clear evidence of infection 1

Antihistamines

  • Limited effectiveness for eczema-related itch
  • May be helpful for nighttime sedation and sleep 4, 6

Allergen Management

  • Consider dietary manipulation only when history strongly suggests food allergy
  • Evidence for house dust mite eradication is not strong 4

Important Considerations and Cautions

Safety of Topical Corticosteroids

  • Risk of skin thinning is low when used appropriately
    • In long-term studies, only 1 case of skin atrophy was reported among 1213 patients using mild/moderate potency TCS for up to 5 years 7
  • Adrenal suppression is rare with appropriate use 7
  • Avoid prolonged use of high-potency corticosteroids on sensitive areas 1

Common Mistakes to Avoid

  • Undertreatment due to "steroid phobia"
  • Prolonged use of high-potency topical corticosteroids on sensitive areas
  • Relying on antihistamines for daytime itch control
  • Using systemic corticosteroids as regular treatment 1

When to Refer to a Specialist

  • Failure to respond to first-line management
  • Uncertain diagnosis
  • Severe or widespread disease
  • Need for systemic therapy 4

Special Populations

  • Children under 2 years: Avoid pimecrolimus 3
  • Sensitive areas (face, neck, skin folds): Prefer topical calcineurin inhibitors over corticosteroids 1

The evidence supports a structured approach to eczema management, with appropriate selection of treatments based on disease severity, affected areas, and response to initial therapy.

References

Guideline

Management of Eczema

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Strategies for using topical corticosteroids in children and adults with eczema.

The Cochrane database of systematic reviews, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2020

Research

Atopic Dermatitis: Diagnosis and Treatment.

American family physician, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.